Publications by the researcher in collaboration with Carlos Briones (14)

2001

  1. Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients

    Intervirology, Vol. 44, Núm. 6, pp. 339-343

  2. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

    Journal of Acquired Immune Deficiency Syndromes, Vol. 26, Núm. 2, pp. 145-150

2000

  1. Can early failure with nevirapine be rescued with efavirenz? [1]

    Journal of Acquired Immune Deficiency Syndromes

  2. Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy

    Virus Research, Vol. 66, Núm. 1, pp. 13-26

  3. Emergence of zidovudine resistance in HIV-infected patients receiving stavudine [1]

    Journal of Acquired Immune Deficiency Syndromes

  4. Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure

    AIDS, Vol. 14, Núm. 11, pp. 1659-1660

  5. Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

    AIDS, Vol. 14, Núm. 6, pp. 727-732

  6. Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals [3]

    Journal of Acquired Immune Deficiency Syndromes

  7. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance

    EMBO Journal, Vol. 19, Núm. 21, pp. 5752-5761

  8. Second Spanish Consensus on the Use of Drug Resistance Testing in Clinical Practice (Madrid, March 2000)

    AIDS Reviews

1999

  1. Incorporacion del examen de resistencias a los antirretrovirales en la practica clinica

    Medicina Clinica

  2. Inhibidores de la proteasa del VIH: Pros y contras

    Medicina Clinica, Vol. 112, Núm. 18, pp. 702-705

  3. Introduction of HIV drug-resistance testing in clinical practice

    AIDS, Vol. 13, Núm. 9, pp. 1007-1014

  4. Usefulness of genotypic analysis of resistance to nucleoside analogues in the clinical setting

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 6, pp. 448-449